Latest Upcoming Webinars

Preclinical models are crucial to studying the association between molecular features of tumor cells and response to chemical perturbations. However, only a few predictors of drug responses have been successfully translated to clinical settings.

Tune into the TME webinar series and listen to the episode “Tumor Microenvironment in a Nutshell” to get a quick refresher on the cause and effect of the TME on tumor development.

The momentous success of mRNA vaccines has prompted the exploration of new analytical approaches for supporting the development, production and deployment of new nucleic acid therapeutics.

Point-of-care testing is the future of diagnostic solutions. The main reason for this is point-of-care testing is robust, easy to use and provides immediate results and thus allows treatment decisions to be made more quickly. As an additional benefit, point-of-care diagnostic testing brings value to patients and healthcare systems.

We are here to help progress point-of-care diagnostics with our glycerol-free enzymes. Lyo-ready enzymes are as efficient and as high in performance as traditional formats of enzymes and this new formulation is suitable for use in microfluidics instruments.

With the genetics behind cancer being both diverse and complex, there are many genomic deviations that need to be detected and analyzed to further our understanding of the disease. Using nanopore sequencing, scientists can achieve the most comprehensive insight into cancer genomes. To explore this further, this symposium will bring together experts in cancer research, where they’ll cover how they are using the technology.

The speakers will discuss detecting missing structural variants, characterizing mutation patterns and how nanopore sequencing has advanced their research.

The tumor microenvironment (TME) is a complex biological network. Understanding interactions within the TME is a crucial step toward effective cancer therapy development. In this webinar, we present Miltenyi Biotec’s novel 3D imaging workflow. It enables simple high-resolution 3D visualization of large solid tumors and their microenvironment by an optimized combination of tissue clearing reagents, validated antibodies for 3D immunofluorescence and the UltraMicroscope Blaze™ light sheet microscope.

Join the webinar to learn how:

• Liver disease progresses from a dysregulation of metabolism
• Lipid metabolism differs between mice and men and the impact this has on drug development
• Primary human NASH models can evaluate drugs that target metabolism
• NASH models allow the quantitation of lipid droplets, metabolism and fibrosis

The tumor microenvironment (TME) is a heterogenous network of various cell types and structural elements. Understanding cell interactions and biological processes within the TME offers possibilities for the development of improved and personalized therapies.

Imaging multiple biomarkers in a single tissue section combined with analysis of their spatial information within the TME enables deep phenotyping and biomarker discovery and can help improve cancer therapy.

In this webinar, we present the unique MACSima™ imaging cyclic staining (MICS) technology from Miltenyi that automates the imaging of hundreds of biomarkers and the associated software that has been specifically developed to analyze multidimensional datasets.